Navigation Links
Statement from the Consumer Healthcare Products Association (CHPA) on Annual Monitoring the Future Survey on Drug Abuse
Date:12/14/2011

WASHINGTON, Dec. 14, 2011 /PRNewswire-USNewswire/ -- Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville issued the following statement regarding today's release of the 2011 National Institute on Drug Abuse's (NIDA's) Monitoring the Future survey, which found that cough medicine abuse among twelfth graders has decreased by 1.2 percent in the last year. Abuse among eighth and tenth graders remained stable, at 2.7 and 5.5 percent respectively. 

"The results of this year's National Institute on Drug Abuse's (NIDA's) Monitoring the Future survey show that abuse of cough medicine has leveled off and even decreased among twelfth graders. However, teens turning to the medicine cabinet to get high remains a persistent and concerning behavior, and the leading makers of over-the-counter medicines will continue our many efforts to stop this behavior.

"Research shows that kids whose parents talk to them about the about the risks of drugs are 50 percent less likely to use. Partnering with drug abuse prevention experts, we have raised awareness among millions of families in communities across the country about the dangers of over-the-counter cough medicine abuse. Through retail initiatives, community events, and media, we will continue to provide information, guidance and support to give parents the tools they need to prevent their teens from abusing cough medicine.

"As we work to empower parents to talk to their teens and to monitor the medicines in their homes, we also are also pushing the federal government to give parents additional support. We continue to call upon Congress to pass a federal bill that would ban individuals under the age of 18 from purchasing cough medicine containing dextromethorphan (DXM). DXM is the most widely used cough suppressant and has been relied upon by American families for more than 50 years, but we recognize some report abusing large quantities. We believe parents should be in control of the medicines that enter their homes, and that teens should not be buying these medicines."

For more information on CHPA's campaign to stop cough medicine abuse, go to StopMedicineAbuse.org.

CHPA is the 130-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

chpa-info.org


 


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nationwide Coalition Responds to Express Scripts CEO Statement: "I Cant Stop Certain Pharmacies From Going Out of Business"
2. Statement from FDA Commissioner Margaret Hamburg, M.D. on Plan B One-Step
3. Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
4. Amgen Statement on European Investor Visit
5. FDA Statement on Makena
6. Cempra Holdings, LLC Files Registration Statement for Proposed Initial Public Offering
7. Alere Inc. Statement Regarding Recommended Increased Cash Offer to Acquire Axis-Shield
8. Alere Inc. Statement Regarding Axis-Shield Offer
9. Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer
10. Visual Healthcare Corp. Files Year-End Disclosure Statement
11. Statement from the Michigan Society of Anesthesiologists in Response to Governor Snyders Health & Wellness Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)... , Feb. 23, 2017  The particle ... million by 2021 from USD 275.9 million in ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... spending on pharmaceutical R&D, and growth in manufacturing ... the market growth for particle counters. On the ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald E. Hawkins, vice ... appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new ... 10. Dr. Bell comes to Liberty from the Ohio University Heritage College of ...
(Date:2/24/2017)... ... February 24, 2017 , ... With millions of ... critically important that we all are aware of our options and are empowered ... to announce the launch of its newest edition of "Vision and Hearing" in ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ProGlass Prism users now have the ability ... total control over position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass ... , With ProGlass Prism users are given the tools and effects to generate ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The International ... 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected ... will be showcased and the winner revealed at the 31st annual iaedp Symposium, March ...
Breaking Medicine News(10 mins):